Table 2 The Median, Min and Max of imaging parameters on baseline imaging (n = 33).

From: Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and 18F-FMISO PET

Category

Parameter

Median

Minimum

Maximum

Anatomical

FLAIR_Vol

101.9

17.9

275.1

FLAIRΔT1

50.5

6.6

188.1

T1_Vol

33.2

0.7

185

T1_Vol_et

19.1

0.1

102.1

T1_Vol_nt

13.1

0.5

115.2

Vol_Ratio

0.4

0

0.8

Perfusion

MTT

4.5

2.7

28.7

MTT_et

4.5

2.7

36.9

MTT_nt

4.1

2.7

20.8

Tmax

4.1

1.3

14.1

Tmax_et

3.6

1.2

14.1

Tmax_nt

4.7

1.4

14.4

nrCBF

1.3

0

5.7

nrCBF_et

1.5

0

6

nrCBF_nt

1.3

0

4.1

nrCBV

1.5

0.6

106.8

nrCBV_et

1.5

0.5

133.2

nrCBV_nt

1.4

0.5

82

srCBV

1.2

0.5

5.1

srCBV_et

1.4

0.5

5.3

srCBV_nt

1.1

0.5

3.2

PET

HV

28.5

0

155.1

Hvmean

1.3

1.2

1.9

SUVmax

2.6

1.3

5.8

SUVpeak

2.1

1

5.2

TB5percent

1.4

1.1

2.9

TBmax

1.9

1.2

3.3

TBpeak

1.6

1.1

3.1

  1. T1_Vol: Tumor volume on post T1 weighted image, T1_Vol_et: enhancing tumor volume, T1_Vol_nt: necrotic tumor tissue volume on post T1 weighted image, srCBV: the mean value within T1_Vol, srCBV_et: the mean value within T1_Vol_et, srCBV_nt: the mean value within T1_Vol_nt, FLAIRΔT1: FLAIR_Vol - T1_Vol, Vol_Ratio: T1_Vol/ FLAIR_Vol.